Inspite of First skepticism, latest advancements in peptide drug discovery have rejuvenated interest in peptides as therapeutic brokers, with about 70 peptides currently marketed and a number of other Many others in clinical development. Current strides in peptide research have unveiled Tirzepatide injections like a beacon of hope for all those